2nd Quarter - Report

DLA PIPER LLP (US) for PLASMA PROTEIN THERAPEUTICS ASSOCIATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement relating to plasma protein therapies.

LobbyistCovered position, as disclosed
NICOLE CARELLI —
VANESSA L. CRAMER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; Patient access to therapies; H.R. 2315/S. 1128, Preserving Access to Orphan Drugs Act; H.R. 460, Patients Access to Treatments Act; H.R. 3116, Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act.

LobbyistCovered position, as disclosed
NICOLE CARELLI —
VANESSA L. CRAMER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2315 (113th), H.R. 3116 (113th), H.R. 460 (113th), S. 1128 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.